| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |